These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2473984)

  • 1. Activation of the contact system of coagulation by a monoclonal antibody directed against a neodeterminant in the heavy chain region of human coagulation factor XII (Hageman factor).
    Nuijens JH; Huijbregts CC; Eerenberg-Belmer AJ; Meijers JC; Bouma BN; Hack CE
    J Biol Chem; 1989 Aug; 264(22):12941-9. PubMed ID: 2473984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody F1 binds to the kringle domain of factor XII and induces enhanced susceptibility for cleavage by kallikrein.
    Ravon DM; Citarella F; Lubbers YT; Pascucci B; Hack CE
    Blood; 1995 Dec; 86(11):4134-43. PubMed ID: 7492770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monoclonal antibody that inhibits activation of human Hageman factor (factor XII).
    Small EJ; Katzmann JA; Tracy RP; Ratnoff OD; Goldsmith GH; Everson B
    Blood; 1985 Jan; 65(1):202-10. PubMed ID: 3965048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monoclonal anti-human plasma prekallikrein antibody that inhibits activation of prekallikrein by factor XIIa on a surface.
    Veloso D; Silver LD; Hahn S; Colman RW
    Blood; 1987 Oct; 70(4):1053-62. PubMed ID: 2443201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
    Revak SD; Cochrane CG; Griffin JH
    J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of activation of the contact system of coagulation in vitro and in vivo: quantitation of activated Hageman factor-C-1-inhibitor and kallikrein-C-1-inhibitor complexes by specific radioimmunoassays.
    Nuijens JH; Huijbregts CC; Cohen M; Navis GO; de Vries A; Eerenberg AJ; Bakker JC; Hack CE
    Thromb Haemost; 1987 Aug; 58(2):778-85. PubMed ID: 2445044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure/function analysis of human factor XII using recombinant deletion mutants. Evidence for an additional region involved in the binding to negatively charged surfaces.
    Citarella F; Ravon DM; Pascucci B; Felici A; Fantoni A; Hack CE
    Eur J Biochem; 1996 May; 238(1):240-9. PubMed ID: 8665943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A monoclonal antibody recognizing an icosapeptide sequence in the heavy chain of human factor XII inhibits surface-catalyzed activation.
    Pixley RA; Stumpo LG; Birkmeyer K; Silver L; Colman RW
    J Biol Chem; 1987 Jul; 262(21):10140-5. PubMed ID: 2440859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity.
    Reddigari SR; Kaplan AP
    Blood; 1989 Aug; 74(2):695-702. PubMed ID: 2752143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The second exon-encoded factor XII region is involved in the interaction of factor XII with factor XI and does not contribute to the binding site for negatively charged surfaces.
    Citarella F; Fedele G; Roem D; Fantoni A; Hack CE
    Blood; 1998 Dec; 92(11):4198-206. PubMed ID: 9834224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a putative binding site for negatively charged surfaces in the fibronectin type II domain of human factor XII--an immunochemical and homology modeling approach.
    Citarella F; te Velthuis H; Helmer-Citterich M; Hack CE
    Thromb Haemost; 2000 Dec; 84(6):1057-65. PubMed ID: 11154114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF; Silver LD; Schapira M; Colman RW
    J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional characterization of factor XII.
    Tans G; Rosing J
    Semin Thromb Hemost; 1987 Jan; 13(1):1-14. PubMed ID: 3551074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiation of contact activation by sulfatides.
    Tans G; Griffin JH
    Adv Exp Med Biol; 1983; 156():63-72. PubMed ID: 6602464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
    Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contact activation mechanism in human plasma: activation induced by dextran sulfate.
    van der Graaf F; Keus FJ; Vlooswijk RA; Bouma BN
    Blood; 1982 Jun; 59(6):1225-33. PubMed ID: 6177360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII).
    Griffin JH
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1998-2002. PubMed ID: 273926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions.
    Sugo T; Kato H; Iwanaga S; Takada K; Sakakibara S
    Eur J Biochem; 1985 Jan; 146(1):43-50. PubMed ID: 3871394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of distinct functional domains on prekallikrein for interaction with both high molecular weight kininogen and activated factor XII in a 28-kDa fragment (amino acids 141-371).
    Page JD; Colman RW
    J Biol Chem; 1991 May; 266(13):8143-8. PubMed ID: 1708772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.